source
- RA Capital, Forbion and Sanofi Ventures back Korean eye-drug startupRA Capital, Forbion and Sanofi Ventures are reported to be providing financing for a new eye-drug company that is developing its product in Korea. The investment follows a growing pattern where la…
- Innoviva revives Lyndra's long-acting oral drug platformInnoviva, a healthcare asset and royalties holding firm, announced it is bringing back Lyndra's long-acting oral drug delivery platform. The technology, which previously attracted more than $380 mi…